📰 Andreaf Wainer News
Page 22 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
March 11, 2024
Trust Co. of Vermont increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.8% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 187,829 shares of the healthcare product maker’s stock after acquiring an additional 12,020 shares during the period. Abbott Laboratories accounts for approximately 1.2% of Trust Co. of Vermont’s […]
March 11, 2024
Trust Co. of Vermont lifted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,829 shares of the healthcare product maker’s stock after acquiring an additional 12,020 […]
March 11, 2024
Chelsea Counsel Co. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,795 shares of the healthcare product maker’s stock after selling 275 shares during the quarter. Abbott Laboratories comprises 1.1% of […]
March 11, 2024
Deutsche Bank AG lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,583,686 shares of the healthcare product maker’s stock after selling 432,200 shares during the period. Deutsche Bank AG owned 0.32% […]
March 9, 2024
Orion Capital Management LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 1,802 shares of the healthcare product maker’s stock, valued at approximately $175,000. Several other institutional investors and hedge funds have also […]
March 9, 2024
Chesapeake Wealth Management lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,319 shares of the healthcare product maker’s stock after selling 234 shares during the quarter. Chesapeake Wealth Management’s holdings […]
March 9, 2024
Chesapeake Wealth Management lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,319 shares of the healthcare product maker’s stock after selling 234 shares during the quarter. […]
February 29, 2024
CWA Asset Management Group LLC lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.5% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,420 shares of the healthcare product maker’s stock after acquiring an additional 183 shares during the quarter. CWA […]
February 29, 2024
CWA Asset Management Group LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,420 shares of the healthcare product maker’s stock after acquiring an additional 183 shares during […]
February 27, 2024
Staley Capital Advisers Inc. cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 48.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,214 shares of the healthcare product maker’s stock after selling 10,606 shares during the quarter. Staley Capital […]